Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Effectiveness and efficiency of imperfect therapeutic HSV-2 vaccines.

Schwartz EJ, Bodine EN, Blower S.

Hum Vaccin. 2007 Nov-Dec;3(6):231-8.

PMID:
17881889
2.

Clinical trials of prophylactic and therapeutic herpes simplex virus vaccines.

Stanberry LR.

Herpes. 2004 Aug;11 Suppl 3:161A-169A. Review.

PMID:
15319086
3.

Modelling the genital herpes epidemic.

Blower S.

Herpes. 2004 Aug;11 Suppl 3:138A-146A. Review.

PMID:
15319083
4.

Vaccines for herpes simplex virus infections.

Koelle DM.

Curr Opin Investig Drugs. 2006 Feb;7(2):136-41. Review.

PMID:
16499283
5.

An update on short-course episodic and prevention therapies for herpes genitalis.

Corey L, Bodsworth N, Mindel A, Patel R, Schacker T, Stanberry L.

Herpes. 2007 Jun;14 Suppl 1:5A-11A. Review.

PMID:
17877886
6.

Reducing the risk of transmitting genital herpes: advances in understanding and therapy.

Leone P.

Curr Med Res Opin. 2005 Oct;21(10):1577-82. Review.

PMID:
16238897
7.

Vaccination strategies to prevent genital herpes and neonatal herpes simplex virus (HSV) disease.

Jones CA, Cunningham AL.

Herpes. 2004 Apr;11(1):12-7. Review.

PMID:
15115632
8.

Introduction: Is viral shedding a surrogate marker for transmission of genital herpes?

Sacks SL, Griffiths PD, Corey L, Cohen C, Cunningham A, Dusheiko GM, Self S, Spruance S, Stanberry LR, Wald A, Whitley RJ.

Antiviral Res. 2004 Aug;63 Suppl 1:S3-9. Review.

PMID:
15450380
9.

The challenge of developing a herpes simplex virus 2 vaccine.

Dropulic LK, Cohen JI.

Expert Rev Vaccines. 2012 Dec;11(12):1429-40. doi: 10.1586/erv.12.129. Review.

10.
11.

Control of STDs--the role of prophylactic vaccines against herpes simplex virus.

Stanberry LR.

Sex Transm Infect. 1998 Dec;74(6):391-4. Review.

12.

Genital herpes vaccines--cause for cautious optimism.

Haddow LJ, Mindel A.

Sex Health. 2006 Mar;3(1):1-4. Review.

PMID:
16607967
13.

[Herpes simplex virus vaccine studies: from past to present].

Us D.

Mikrobiyol Bul. 2006 Oct;40(4):413-33. Review. Turkish.

PMID:
17205702
14.

Potential prophylactic and therapeutic vaccines for HSV infections.

Ramachandran S, Kinchington PR.

Curr Pharm Des. 2007;13(19):1965-73. Review.

PMID:
17627530
15.

HSV-2: in pursuit of a vaccine.

Johnston C, Koelle DM, Wald A.

J Clin Invest. 2011 Dec;121(12):4600-9. doi: 10.1172/JCI57148. Epub 2011 Dec 1. Review.

16.

Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy.

Pepose JS, Keadle TL, Morrison LA.

Am J Ophthalmol. 2006 Mar;141(3):547-557. Review.

PMID:
16490506
17.

Herpes. Vaccines for HSV.

Stanberry LR.

Dermatol Clin. 1998 Oct;16(4):811-6, xiv. Review.

PMID:
9891686
18.

Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection.

Lingappa JR, Celum C.

Drugs. 2007;67(2):155-74. Review. Erratum in: Drugs. 2007;67(8):1147.

PMID:
17284082
19.

Glycoprotein D adjuvant herpes simplex virus vaccine.

Bernstein D.

Expert Rev Vaccines. 2005 Oct;4(5):615-27. Review.

PMID:
16221064
20.

Antivirals in the prevention of genital herpes.

Au E, Sacks SL.

Herpes. 2002 Dec;9(3):74-7. Review.

PMID:
12470605
Items per page

Supplemental Content

Write to the Help Desk